Finally, patient-derived glioma stem cells from IDHmut tumors significantly downregulate the natural killer (NK) cell activating ligand NKG2D compared to those from IDH-wild type patients, leading to blunted NK cell-mediated lysis (29). Here, IDH1 is linked to central nervous system cancer.